Could an old allergy drug shrink enlarged prostates?
NCT ID NCT06689514
First seen Jan 10, 2026 · Last updated Jun 12, 2026 · Updated 24 times
Summary
This early-stage study tests whether tranilast, a drug used for allergies, can reduce prostate size in 30 men aged 55-75 with moderate to severe urinary symptoms. The drug targets mast cells, which may drive prostate growth. Researchers will measure changes in prostate volume, symptom scores, and quality of life over the study period.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC HYPERTROPHY, BENIGN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, Outside U.S./Canada, 200086, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai General Hospital
NOT_YET_RECRUITINGShanghai, 200086, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.